Quick Answer
LISATA THERAPEUTICS, INC. reported Net Income of -$16.59 million for fiscal year 2025.
LISATA THERAPEUTICS, INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$16.59M | +17.0% |
| 2024 | -$19.98M | +4.1% |
| 2023 | -$20.84M | +61.6% |
| 2022 | -$54.23M | -97.4% |
| 2021 | -$27.47M | -237.0% |
| 2020 | -$8.15M | +57.9% |
| 2019 | -$19.36M | -19.8% |
| 2018 | -$16.17M | -170.4% |
| 2017 | $22.98M | +170.4% |
| 2016 | -$32.66M | +40.5% |
| 2014 | -$54.87M | -40.8% |
| 2013 | -$38.98M | +27.5% |
| 2012 | -$53.77M | -14.1% |
| 2011 | -$47.13M | -102.2% |
| 2010 | -$23.31M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$4.25M | +13.8% | +8.8% |
| June 30, 2025 | -$4.66M | +7.6% | +1.4% |
| March 31, 2025 | -$4.72M | +12.5% | +4.2% |
| September 30, 2024 | -$4.93M | +6.3% | +2.3% |
| June 30, 2024 | -$5.04M | -25.3% | +6.6% |
| March 31, 2024 | -$5.40M | +12.7% | -2.7% |
| September 30, 2023 | -$5.26M | +85.9% | -30.6% |
| June 30, 2023 | -$4.03M | +39.2% | +34.9% |
- LISATA THERAPEUTICS, INC. showed an increase of +17.0% in Net Income compared to the prior fiscal year.
- Over the 2010–2025 period, LISATA THERAPEUTICS, INC.’s net income has grown by 28.8% (from -$23.31 million to -$16.59 million).
- The most recent figure is from LISATA THERAPEUTICS, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: